Heart Failure: Vericiguat Study

We are studying the effects of vericiguat in patients with heart failure and reduced ejection fraction. The goal is to see if it can lower heart failure markers compared to a placebo.

3-6 months 6-10 visits Monitoring phase (IV)Cost Reimbursement Partially Remote Standard Medicines OralCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Verquvo

Verquvo is a medicine used to reduce the risk of worsening heart failure and related hospital stays in adults.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Vericiguat

Vericiguat is a substance that helps relax blood vessels and improve heart pumping to reduce worsening heart failure and hospitalizations.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Aarhus Universitet

Cardiology

Århus, Denmark

Rigshospitalet

Cardiology

Copenhagen, Denmark

Odense University Hospital

Cardiology

Odense, Denmark

Sponsor: Rigshospitalet

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.